These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 6440827)

  • 1. Worsening of arrhythmias during pharmacological treatment.
    Furlanello F; Gramegna L; Dal Forno P; Vergara G; Bettini R; Inama G; Disertori M
    G Ital Cardiol; 1984 Oct; 14(10):798-803. PubMed ID: 6440827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P; Leclercq JF; Assayag P; Maisonblanche P; Cauchemez B
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1370-82. PubMed ID: 6439161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drugs in the management of ventricular arrhythmias.
    Sanna GP
    G Ital Cardiol; 1984 Oct; 14(10):788-97. PubMed ID: 6083894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
    Podrid PJ
    Chest; 1985 Oct; 88(4):618-24. PubMed ID: 3930162
    [No Abstract]   [Full Text] [Related]  

  • 5. [Validity and limits of invasive pharmacological tests in the treatment of malignant ventricular hyperkinetic arrhythmias].
    Disertori M; Vergara G; Inama G; Guarnerio M; Furlanello F; Botti G; Bonatti V; Rolli A
    G Ital Cardiol; 1983; 13(4):311-4. PubMed ID: 6884675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug therapy of arrhythmia in coronary cardiopathy].
    Lüderitz B
    Clin Ter; 1983 Apr; 105(1):3-11. PubMed ID: 6189663
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic drug therapy. Recent advances and current status.
    Somberg J
    Cardiology; 1985; 72(5-6):329-48. PubMed ID: 2866841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F; Palmieri M; del Corso P; Lombardi G; Bracchetti D
    Arzneimittelforschung; 1982; 32(5):547-50. PubMed ID: 7201833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative studies of tocainide and propafenone in the treatment of ventricular arrhythmias].
    Gebhardt A; Schmuderer R; Hilpert P
    Arzneimittelforschung; 1984; 34(3):303-6. PubMed ID: 6428425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propafenone for the treatment of severe ventricular arrhythmias.
    Rabkin SW; Rotem CE; Boroomand-Rashti K; Bar-Shlomo B
    Can Med Assoc J; 1984 Sep; 131(6):601-3. PubMed ID: 6478345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic effectiveness of propafenone compared to lorajmine in ventricular arrhythmias. Controlled clinical trial.
    Sanna G; Meoli P; Bianchini C; Rovelli F
    G Ital Cardiol; 1983; 13(3):145-51. PubMed ID: 6350090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tocainide and prajmalium bitartrate for the treatment of ventricular arrhythmias.
    Schwartzkopff B; Schilling G; Simon H
    Arzneimittelforschung; 1983; 33(1):153-8. PubMed ID: 6403021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F; Grävinghoff L; Grütte E; Jüngst BK; Liersch R; Nomayo H; Puls I; Rautenburg HW; Schmaltz A; Schumacher G
    Monatsschr Kinderheilkd; 1985 Mar; 133(3):154-7. PubMed ID: 4010670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic effect of lorcainide during chronic treatment.
    Meinertz T; Kasper W; Kersting F; Bechtold H; Just H; Jähnchen E
    Arzneimittelforschung; 1980; 30(9):1593-5. PubMed ID: 7193031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drugs for treatment of ventricular arrhythmias.
    Heger JJ; Prystowsky EN; Zipes DP
    Heart Lung; 1981; 10(3):475-83. PubMed ID: 6785255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sustained ventricular tachycardia: induced polymorphism. Clinical and electrophysiological aspects; therapeutic implications].
    Vergara G; Disertori M; Inama G; Guarnerio M; Bettini R; Durante G; Stirpe E; Furlanello F
    G Ital Cardiol; 1984 Dec; 14(12):972-81. PubMed ID: 6532893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Worsening of ventricular arrhythmia in the dynamic ECG in patients treated with anti-arrhythmia drugs].
    Lanza GA; Tamburi S; Mondello Malvestiti FM; Rebuzzi AG; Lucente M
    Cardiologia; 1988 Jun; 33(6):613-8. PubMed ID: 3139292
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
    Hashimoto K; Ishii M; Komori S; Mitsuhashi H
    Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.